Delivery Order SPE2DR25D2003-SPE2DR26FR06V
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count packaging) with a ceiling value of $1,573.01. This firm fixed-price delivery order is scheduled for ultimate completion by July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation applied. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count units) with a ceiling value of $2,963.45. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on September 8, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count). The order, valued at $6,729.58, represents a firm fixed-price delivery order with an ultimate completion date of September 9, 2025. This award was not designated as a set-aside contract and was competitively awarded through open competition. The product will be delivered to the place of performance in...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.29 to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets (500-count units). This competitive, firm fixed-price contract is scheduled for completion by December 31, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under a larger contract vehicle supporting federal pharmaceutical procurement. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mucus Relief ER 600 mg tablets in unit dose packaging (100 count) with a contract value of $2,846.14. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Mucus Relief DM ER 600-30 mg tablets (40-count package) with a ceiling value of $2,917.37. This is a firm fixed-price delivery order with a completion date of October 20, 2025, issued with no set-aside designation under competitive procurement procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,731.84 to AmerisourceBergen Drug Corp for Mucus Relief D ER 600-60 mg tablets (18-count) on December 16, 2025, with an ultimate completion date of December 17, 2025. This firm fixed-price delivery order carries no set-aside designation and was awarded through open competition. The contract is being fulfilled from the vendor's location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets (500-count packages) with a ceiling value of $1,150.23. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, was structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance of this contract is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets (500-count units) with a ceiling value of $1,641.44. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation, indicating it was...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Mucus Relief ER 600 mg tablets (500-count bottles) with a ceiling value of $1,195.33 under a firm fixed-price contract type. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation,...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR06VDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Mucus Relief ER 600 mg tablets (500 count) with a contract ceiling value of $1,613.46. This firm fixed-price delivery order is scheduled for completion by January 6, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive, non-set-aside procurement and is classified as a child contract under a larger vehicle. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to deliver a wide range of medications, vaccines, and medical supplies to support military healthcare programs and other government healthcare systems worldwide. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and affiliated military medical services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/4/26 |